# Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis

> **NCT03187431** · PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 12 (estimated)

## Conditions studied

- Stem Cell Transplant Complications

## Interventions

- **BIOLOGICAL:** autologous bone marrow mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03187431
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-11
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187431, "Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03187431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*